Bryan M. Reasons
CIK 1553489 · EVP & CFO · last filed 2025-08-04
Bryan M. Reasons is an EVP & CFO who has filed 57 SEC Form 4 insider transactions across 6 companies since 2013. Across all open-market trades the lifetime net is −$204.2K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.5M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$1.47M
6
57
-$204.2K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ACRS | Director | 28,732 | $4.32 | $124.1K | $0 | 8 | 2024-06-04 |
| Societal CDMO, Inc. (SCTL) Delisted | Director | 0 | $1.10 | $0 | $25.0K | 4 | 2024-04-08 |
| Keenova Therapeutics plc (MNK) Delisted | EVP & CFO | 96,660 | $0.34 | $32.9K | $47.5K | 9 | 2023-08-18 |
| Societal CDMO, Inc. (REPH) Delisted | Director | 67,429 | $2.09 | $140.9K | $0 | 10 | 2021-05-17 |
| AMRX | CFO | 82,986 | $16.20 | $1.34M | -$276.7K | 2 | 2018-08-23 |
| Impax Laboratories, LLC (IPXL) Delisted | Chief Financial Officer | 94,684 | — | — | $0 | 19 | 2018-03-05 |
Recent Filings
57 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-08-04 | — | Grant (A) | — | $0 | |
| 2025-01-02 | — | Mixed | +5,114 | $0 | |
| 2024-06-04 | ACRS | Exer (M) | +4,660 | $0 | EDGAR |
| 2024-04-08 | Societal CDMO, Inc. (SCTL) Delisted | Mixed | −291,049 | -$320.2K | EDGAR |
| 2024-02-06 | — | Grant (A) | — | $0 | |
| 2023-11-16 | — | Disp (D) | −96,660 | $0 | |
| 2023-08-28 | Societal CDMO, Inc. (SCTL) Delisted | Buy (P) | +62,500 | $25.0K | EDGAR |
| 2023-08-18 | Keenova Therapeutics plc (MNK) Delisted | Tax (F) | −15,976 | -$11.1K | EDGAR |
| 2023-07-05 | Keenova Therapeutics plc (MNK) Delisted | Disp (D) | — | $0 | EDGAR |
| 2023-06-05 | ACRS | Mixed | +4,507 | $0 | EDGAR |